For instance, CEA cystic fluid levels more than 192 ng/mL and/or the presence of a KRAS mutation support the diagnosis of mucinous neoplastic cyst, while a GNAS mutation the diagnosis of IPMN [5,20,21,22,23]. Here, KRAS is linked to pancreatic intraductal papillary-mucinous neoplasm.